Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

VIAMEROP

Class 5Status: Accepted & Advertised
Application Number5551790
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2022-07-30
Proprietor NameMYLAN LABORATORIES LIMITED
Appropriate OfficeCHENNAI
StateTELANGANA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameSAIKRISHNA & ASSOCIATES[9287]
Agent AddressB-140, SEC-51, NOIDA-201301
Goods And Services Details[CLASS : 5] Medicinal and Pharmaceutical Preparations for the treatment of infections

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
VIAMEROP5Accepted & Advertised
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about VIAMEROP.

What is the status of trademark application 5551790?
The current status of trademark application 5551790 for VIAMEROP is Accepted & Advertised.
What is the trademark class of VIAMEROP?
VIAMEROP is registered under trademark class 5.
Who is the proprietor of VIAMEROP?
The proprietor of VIAMEROP is MYLAN LABORATORIES LIMITED.
When was trademark application 5551790 filed?
Trademark application 5551790 for VIAMEROP was filed on 2022-07-30.